Publications | UCSF Philip R. Lee Institute for Health Policy Studies

Home delivery of legal intoxicants in the age of COVID-19.

Matthay EC, Schmidt LA

Addiction 2021 Apr doi: 10.1111/add.15289

The case for prescribing PrEP in community mental health settings.

Sudler A, Cournos F, Arnold E, Koester K, Riano NS, Dilley J, Liu A, Mangurian C

Lancet HIV 2021 Apr doi: 10.1016/S2352-3018(20)30273-3

Emergency Visits and Hospitalizations for Child Abuse During the COVID-19 Pandemic.

Kaiser SV, Kornblith AE, Richardson T, Pantell MS, Fleegler EW, Fritz CQ, Parikh K, Zagel A, Sills MR, Souza HG, Goyal MK, Hogan AH, Heller KR, DeLaroche AM, Cooper JN, Puls HT

Pediatrics 2021 Apr doi: 10.1542/peds.2020-038489

Feasibility of brief distress screening for family caregivers of adults diagnosed with schizophrenia in Changsha, Hunan, China.

Guan Z, Cross W, Lam L, Wiley JA, Sun M, Bai X, Tang S

J Psychiatr Ment Health Nurs 2021 Apr doi: 10.1111/jpm.12663

NEXT Harm Reduction: An Online, Mail-Based Naloxone Distribution and Harm-Reduction Program.

Yang C, Favaro J, Meacham MC

Am J Public Health 2021 Apr doi: 10.2105/AJPH.2020.306124

Patient Factors Associated With Parathyroidectomy in Older Adults With Primary Hyperparathyroidism.

Seib CD, Suh I, Meng T, Trickey A, Smith AK, Finlayson E, Covinsky KE, Kurella Tamura M, Kebebew E

JAMA Surg 2021 Apr doi: 10.1001/jamasurg.2020.6175

Effects of a minimum floor Price law on cigarette use in Oakland, California: A static microsimulation model.

Boettiger DC, White JS

Prev Med 2021 Apr doi: 10.1016/j.ypmed.2021.106444

School closures reduced social mixing of children during COVID-19 with implications for transmission risk and school reopening policies.

By: Head JR, Andrejko KL, Cheng Q, Collender PA, Phillips S, Boser A, Heaney AK, Hoover CM, Wu SL, Northrup GR, Click K, Bardach NS, Lewnard JA, Remais JV

J R Soc Interface 2021 Apr doi: 10.1098/rsif.2020.0970

Variation in COVID-19 Mortality Across 117 US Hospitals in High- and Low-Burden Settings.

Block BL, Martin TM, Boscardin WJ, Covinsky KE, Mourad M, Hu LL, Smith AK

J Hosp Med 2021 Apr doi: 10.12788/jhm.3612

Type I interferon, anti-interferon antibodies, and COVID-19.

Calabrese LH, Winthrop K, Strand V, Yazdany J, Walter JE

Lancet Rheumatol 2021 Apr doi: 10.1016/S2665-9913(21)00034-5